# Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

> **NCT00347139** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 55 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GW642444 (25, 100 & 400 mcg/day)
- **DRUG:** Salmeterol 50mcg

## Key facts

- **NCT ID:** NCT00347139
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-23
- **Primary completion:** 2007-01-10
- **Final completion:** 2007-01-10
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00347139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00347139, "Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00347139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*